CONTENTS

IceCure Medical Ltd. (the “Company”) is filing this Amendment No. 1 (the “Amendment”) to its Report of Foreign Private Issuer on Form 6-K as furnished with the U.S. Securities and Exchange Commission (“SEC”) on July 28, 2025 (the “Form 6-K”). On July 28, 2025, the Company furnished on the Form 6-K a Notice of Meeting, Proxy Statement and Proxy Card for the Special General Meeting of Shareholders to be held on Monday, September 1, 2025 (the “Meeting”). The Company is amending the Form 6-K and replacing the previously published Notice of Meeting and Proxy Statement furnished with the Form 6-K as Exhibits 99.1 and 99.2 thereto, respectively, in their entirety for the sole purpose of including the URL website address for shareholders to attend the Meeting, which is taking place by means of remote communication only. No changes were made to Exhibit 99.3 to the Form 6-K.

The Company hereby is furnishing the amended Notice of Meeting and amended Proxy Statement hereto as Exhibits 99.1 and 99.2, respectively.

Only shareholders of record who hold ordinary shares, no par value, of the Company at the close of business on Monday, August 4, 2025, will be entitled to notice of and to vote at the Meeting and any postponements or adjournments thereof.

This Amendment to the Form 6-K is incorporated by reference into the Company’s Registration Statements on Form F-3 (File Nos. 333-267272 and 333-258660) and Form S-8 (File Nos. 333-270982, 333-264578, 333-262620 and 333-281587), filed with the Securities and Exchange Commission, to be a part thereof from the date on which this Amendment to the Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.